Literature DB >> 2851309

Measurement of oestrogen receptor mRNA levels in human breast tumours.

J A Henry1, S Nicholson, J R Farndon, B R Westley, F E May.   

Abstract

A sensitive single-stranded hybridisation probe for the oestrogen receptor mRNA was synthesised using T3 polymerase from oestrogen receptor cDNA cloned in the Bluescript vector. This probe was used to measure oestrogen receptor mRNA in total RNA extracted from breast tumours. Oestrogen receptor mRNA was detected in 41 of 47 (87%) tumours whereas cytosolic oestrogen receptor protein was detected in only 18 out of 39 (46%). There was a significant correlation between the levels of the oestrogen receptor, as measured by 3H-oestradiol binding, and the oestrogen receptor mRNA. Oestrogen receptor mRNA was detected in 15 of the 21 tumours that did not contain detectable oestrogen receptor protein. This suggests that detection of the mRNA is a more sensitive means for establishing oestrogen receptor status than the radioligand oestrogen receptor assay. Oestrogen receptor mRNA was found in all histological tumour types examined. Its level was related to tumour differentiation. All the tumours that did not contain oestrogen receptor mRNA and most of the tumours that contained only low levels of oestrogen receptor mRNA were classified as grade III according to Bloom and Richardson: the median of the oestrogen receptor mRNA levels was significantly lower in this group.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851309      PMCID: PMC2246829          DOI: 10.1038/bjc.1988.267

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Cloning of estrogen-regulated messenger RNA sequences from human breast cancer cells.

Authors:  F E May; B R Westley
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

2.  Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method.

Authors:  S M Thorpe
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

3.  Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.

Authors:  R R Reddel; L C Murphy; R E Hall; R L Sutherland
Journal:  Cancer Res       Date:  1985-04       Impact factor: 12.701

4.  Detection of estrogen receptor mRNA in human uterus.

Authors:  F F Parl; C P Schonbaum; D L Cox; D R Cavener
Journal:  Mol Cell Endocrinol       Date:  1987-08       Impact factor: 4.102

5.  Heterogeneity of soluble and nuclear oestrogen receptor status of involved nodes in relation to primary breast cancer.

Authors:  L Castagnetta; A Traina; A Di Carlo; A M Latteri; G Carruba; R E Leake
Journal:  Eur J Cancer Clin Oncol       Date:  1987-01

6.  Characterization of estrogen receptor messenger RNA in human breast cancer.

Authors:  P J Barrett-Lee; M T Travers; R A McClelland; Y Luqmani; R C Coombes
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

7.  Cloning of the human estrogen receptor cDNA.

Authors:  P Walter; S Green; G Greene; A Krust; J M Bornert; J M Jeltsch; A Staub; E Jensen; G Scrace; M Waterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates.

Authors:  R C Coombes; T J Powles; U Berger; P Wilson; R A McClelland; J C Gazet; P A Trott; H T Ford
Journal:  Lancet       Date:  1987-09-26       Impact factor: 79.321

9.  Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells.

Authors:  B R Westley; F E May
Journal:  Nucleic Acids Res       Date:  1987-05-11       Impact factor: 16.971

10.  Heterogeneous estrogen receptor levels detected via multiple microsamples from individual breast cancers.

Authors:  J P van Netten; F T Algard; P Coy; S J Carlyle; M L Brigden; K R Thornton; S Peter; T Fraser; M P To
Journal:  Cancer       Date:  1985-10-15       Impact factor: 6.860

View more
  18 in total

1.  Analysis of estrogen receptor messenger RNA in breast carcinomas from archival specimens is predictive of tumor biology.

Authors:  C Carmeci; E C deConinck; T Lawton; D A Bloch; R J Weigel
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers.

Authors:  Z Tang; I Treilleux; M Brown
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

3.  Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line.

Authors:  W W Kuang; D A Thompson; R V Hoch; R J Weigel
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

4.  Estrogen receptors in human preadipocytes.

Authors:  J M Joyner; L J Hutley; D P Cameron
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

Review 5.  Mechanisms of estrogen receptor-α upregulation in breast cancers.

Authors:  Yasuo Miyoshi; Keiko Murase; Masaru Saito; Michiko Imamura; Koushi Oh
Journal:  Med Mol Morphol       Date:  2011-01-26       Impact factor: 2.309

6.  Tissue-Specific Expression of Estrogen Receptor 1 Is Regulated by DNA Methylation in a T-DMR.

Authors:  Ryo Maekawa; Shun Sato; Maki Okada; Lifa Lee; Isao Tamura; Kosuke Jozaki; Takuya Kajimura; Hiromi Asada; Yoshiaki Yamagata; Hiroshi Tamura; Shigeru Yamamoto; Norihiro Sugino
Journal:  Mol Endocrinol       Date:  2015-12-18

7.  Differential protein expression profiles in estrogen receptor-positive and -negative breast cancer tissues using label-free quantitative proteomics.

Authors:  Karim Rezaul; Jay Kumar Thumar; Deborah H Lundgren; Jimmy K Eng; Kevin P Claffey; Lori Wilson; David K Han
Journal:  Genes Cancer       Date:  2010-03

Review 8.  Timing of dietary fat exposure and mammary tumorigenesis: role of estrogen receptor and protein kinase C activity.

Authors:  L Hilakivi-Clarke; R Clarke
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

9.  Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.

Authors:  Isabel Chu; Angel Arnaout; Sophie Loiseau; Jun Sun; Arun Seth; Chris McMahon; Kathy Chun; Bryan Hennessy; Gordon B Mills; Zafar Nawaz; Joyce M Slingerland
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

10.  A candidate molecular signature associated with tamoxifen failure in primary breast cancer.

Authors:  Julie A Vendrell; Katherine E Robertson; Patrice Ravel; Susan E Bray; Agathe Bajard; Colin A Purdie; Catherine Nguyen; Sirwan M Hadad; Ivan Bieche; Sylvie Chabaud; Thomas Bachelot; Alastair M Thompson; Pascale A Cohen
Journal:  Breast Cancer Res       Date:  2008-10-17       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.